Valuation: Karex

Market Cap 427M 104M 93.26M 86.15M 78.07M 146M 9.91B 148M 1.04B 410M 5.19B 392M 384M 16.38B P/E 2026
1,600x
P/E 2027 * 22.5x
Enterprise Value 427M 104M 93.26M 86.15M 78.07M 146M 9.91B 148M 1.04B 410M 5.19B 392M 384M 16.38B EV / Sales 2026
1.09x
EV / Sales 2027 * 0.83x
Free-Float
39.68%
Yield 2026
2.08%
Yield 2027 * 2.3%
1 day-1.22%
1 week-8.99%
Current month-7.95%
1 month-8.99%
3 months-19.00%
6 months-29.57%
Current year-42.55%
1 week 0.4
Extreme 0.4
0.44
1 month 0.4
Extreme 0.4
0.48
Current year 0.4
Extreme 0.4
0.73
1 year 0.4
Extreme 0.4
0.95
3 years 0.4
Extreme 0.4
1.09
5 years 0.32
Extreme 0.325
1.09
10 years 0.26
Extreme 0.26
2.62
Manager TitleAgeSince
Chief Executive Officer 48 29/07/2013
Director of Finance/CFO 49 30/06/2025
Chief Tech/Sci/R&D Officer 71 27/09/2012
Director TitleAgeSince
Director/Board Member 71 27/09/2012
Director/Board Member 83 30/11/2012
Director/Board Member 48 25/02/2020
Date Insider Type Main position Quantity % Market Cap. Importance
16/7/26 Free

Director

80,000 0.0076%
16/7/26 Free

Chief Technology Officer

80,000 0.0076%
16/7/26 Free

Chief Executive Officer

80,000 0.0076%
Change 5-day change 1-year change 3-year change Capi.($)
-1.22%-8.99%-55.98%-28.95% 104M
-2.12%+1.05%+5.79%+8.69% 374B
+5.64%+7.09%+16.27%+12.78% 260B
-0.76%-0.57%-6.32%+10.05% 142B
-3.44%-0.07%+19.89%+30.68% 74.97B
+2.33%+8.52%+36.76% - 54B
-0.74%-4.18%-30.25%-26.93% 44.92B
+0.88%+3.95%+9.23%-20.66% 39.32B
-1.56%+3.49%+29.69%-0.56% 37.59B
-1.93%+4.34%-7.25%-9.57% 36.63B
Average -0.29%+2.43%+1.78%-2.72% 106.39B
Weighted average by Cap. +0.29%+4.59%+8.29%+7.83%

Financials

2026 2027 *
Net sales 483M 118M 106M 97.49M 88.35M 165M 11.22B 168M 1.17B 464M 5.88B 443M 434M 18.53B 515M 126M 113M 104M 94.27M 176M 11.97B 179M 1.25B 496M 6.27B 473M 463M 19.77B
Net income -5.82M -1.42M -1.27M -1.18M -1.06M -1.99M -135M -2.03M -14.14M -5.6M -70.85M -5.35M -5.23M -223M 19.2M 4.7M 4.2M 3.88M 3.51M 6.57M 446M 6.68M 46.65M 18.47M 234M 17.64M 17.26M 737M
Net Debt - -
Projected Income Statement - Annual - Karex
Logo Karex
Karex Berhad is a Malaysia-based investment holding company. The Company has three segments. Sexual Wellness segment is engaged in the sale of condoms, personal lubricants and sex toys. Medical segment is engaged in the sale of catheters, probe covers, human immunodeficiency virus (HIV) and pregnancy test kits, and other medical related products. Other segment is engaged in the sale of products not related to sexual wellness and medical. Its subsidiaries, including Hevea Medical Sdn. Bhd., Innolatex Sdn. Bhd., Innolatex (Thailand) Limited, Karex Industries Sdn. Bhd. and Medical-Latex (Dua) Sdn. Bhd. are engaged in the manufacturing and selling of condoms, rubber products, personal lubricants, and others. Its subsidiary, Karex Marketing Sdn. Bhd. engages in manufacturing and selling hand sanitizers, condoms, personal lubricants, and others. Its subsidiaries, Karex Global Limited, Karex Holdings Sdn. Bhd., Karex International Sdn. Bhd. are engaged in investment holding activity.
Employees
3,061
Date Price Change Volume
23/10/26 MYR 0.4050 -1.22% 585,000
22/10/26 MYR 0.4100 0.00% 352,600
21/10/26 MYR 0.4100 -2.38% 646,200
20/10/26 MYR 0.4200 -4.55% 634,500
19/10/26 MYR 0.4400 -1.12% 104,800
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Karex
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.4050MYR
Average target price
0.5833MYR
Spread / Average Target
+44.03%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Karex
  1. Stock Market
  2. Stocks
  3. 5247 Stock